Evotec AG (investor - Corporate Investor)

See something wrong or missing? Let us know
Offices:Hamburg

Evotec SE is a publicly listed drug discovery and development company that operates globally, largely through external alliances with pharmaceutical and biotechnology companies, academic institutions, patient advocacy groups, and venture capitalists.

Average round investment:48.9M USD
Average number per year:1.5
Distribution: 2024 (2)2022 (3)2021 (1)2020 (1)2019 (1) See the entire list
Mostly invests in: United Kingdom United Kingdom (6) Biotech (9)
See the entire list

Showing 3 of 9 tracked investments in:


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Evotec AG mostly invests with:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Evotec AG

Name Criteria
Germany 415 Capital
79%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Software Services, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.5
Switzerland Metellus AG
79%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.5
United Kingdom Perscitus LLP
79%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Software Services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.5
United States Shasta Ventures
79%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Software Services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Germany
  • Average number of deals per year: 1.5
Germany TruVenturo
79%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Software Services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.5
Germany Wachstumsfonds Bayern
79%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Software Services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.5
United Kingdom Wheatsheaf Group
79%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Ireland
  • Average number of deals per year: 1.5
Germany Cumberland VC
79%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Software Services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.5
United States Delphi VC
79%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Software Services, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.5
United States Digitalis Ventures
79%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.5
Top